We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+10.98%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$40.7B
AUM Growth
-$4.56M
Cap. Flow
-$3.46B
Cap. Flow %
-8.5%
Top 10 Hldgs %
19.9%
Holding
801
New
88
Increased
169
Reduced
396
Closed
90

Top Buys

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$165M
2
COST icon
Costco
COST
+$134M
3
BMY icon
Bristol-Myers Squibb
BMY
+$126M
4
JCI icon
Johnson Controls International
JCI
+$121M
5
MMM icon
3M
MMM
+$112M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$1.48B
2
AAPL icon
Apple
AAPL
+$136M
3
MPC icon
Marathon Petroleum
MPC
+$123M
4
CNP icon
CenterPoint Energy
CNP
+$123M
5
UAA icon
Under Armour
UAA
+$117M

Sector Composition

Rank Sector Weight
1 Technology 17.42%
2 Healthcare 16.85%
3 Financials 12.9%
4 Consumer Discretionary 10.95%
5 Industrials 10.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GDP
676
DELISTED
Goodrich Petroleum Corporation Common Stock
GDP
$1.19M ﹤0.01%
118,201
+100,000
+549% +$972K
FPRX
677
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$1.15M ﹤0.01%
250,000
-1,000,000
-80% -$3.96M
ARYAW
678
DELISTED
ARYA Sciences Acquisiton Corp. Warrant
ARYAW
$1.07M ﹤0.01%
625,000
TVTX icon
679
Travere Therapeutics
TVTX
$5.2B
$1.06M ﹤0.01%
75,000
-25,000
-25% -$319K
KRNY icon
680
Kearny Financial
KRNY
$604M
$1.04M ﹤0.01%
75,000
-7,300
-9% -$101K
CUB
681
DELISTED
Cubic Corporation
CUB
$892K ﹤0.01%
14,036
SPAQ.WS
682
DELISTED
Spartan Energy Acquisition Corp. Warrants, each whole warrant exercisable for one Class A common sto
SPAQ.WS
$871K ﹤0.01%
1,584,000
PD icon
683
PagerDuty
PD
$816M
$819K ﹤0.01%
+35,000
New +$861K
NTNX icon
684
Nutanix
NTNX
$16B
$782K ﹤0.01%
+25,000
New +$738K
INDP icon
685
Indaptus Therapeutics
INDP
$172M
$730K ﹤0.01%
652
KURA icon
686
Kura Oncology
KURA
$800M
$688K ﹤0.01%
50,000
BRY
687
DELISTED
Berry Corp
BRY
$660K ﹤0.01%
70,000
-550,000
-89% -$5.14M
CMTL icon
688
Comtech Telecommunications
CMTL
$50.3M
$657K ﹤0.01%
18,499
MOG.A icon
689
Moog Inc Class A
MOG.A
$12.4B
$644K ﹤0.01%
7,553
SIOX
690
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$640K ﹤0.01%
125,000
CNDT icon
691
Conduent
CNDT
$244M
$620K ﹤0.01%
+100,000
New +$626K
SPR
692
DELISTED
Spirit AeroSystems
SPR
$610K ﹤0.01%
8,376
-164,122
-95% -$13.5M
RYTM icon
693
Rhythm Pharmaceuticals
RYTM
$6.81B
$574K ﹤0.01%
25,000
ADNWW
694
DELISTED
Advent Technologies Holdings Warrant
ADNWW
$558K ﹤0.01%
1,800,000
DBVT
695
DBV Technologies
DBVT
$799M
$535K ﹤0.01%
5,000
GCVRZ
696
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$529K ﹤0.01%
614,455
IHRT icon
697
iHeartMedia
IHRT
$543M
$505K ﹤0.01%
+29,859
New +$452K
FSLY icon
698
Fastly Inc
FSLY
$3.55B
$502K ﹤0.01%
25,000
SBE.WS
699
DELISTED
Switchback Energy Acquisition Corporation Warrants, exercisable for one share of Class A Common Stoc
SBE.WS
$480K ﹤0.01%
+800,000
New +$581K
SHLL.WS
700
DELISTED
Tortoise Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common
SHLL.WS
$474K ﹤0.01%
1,012,500

Similar funds

Adage Capital Partners's Q4 2019 Portfolio in Review

As of Q4 2019, Adage Capital Partners held 801 positions worth $40.7B, down 0.01% from $40.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Adage Capital Partners withdrew a net $3.46B in Q4 2019, closing 90 positions and reducing 396 holdings. Its most notable exit was Celgene Corp, an estimated $1.48B position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Adage Capital Partners opened a new position in Bristol-Myers Squibb worth $142M.

  • Adage Capital Partners's largest Q4 2019 buy was Bristol-Myers Squibb: 2,207,539 shares worth $142M.
  • Adage Capital Partners added most to RTX Corp in Q4 2019, an estimated $165M increase.
  • Adage Capital Partners's biggest Q4 2019 reduction was Apple, cutting an estimated $136M.
  • Adage Capital Partners fully exited Celgene Corp in Q4 2019, selling an estimated $1.48B.
  • Adage Capital Partners's ten largest holdings make up 20% of its $40.7B portfolio in Q4 2019.
  • Adage Capital Partners opened 88 new positions and closed 90 in Q4 2019.
  • Adage Capital Partners's portfolio value fell 0.01% quarter-over-quarter to $40.7B.

Based on Adage Capital Partners's 13F filing for Q4 2019, filed 14 Feb 2020.